Genomic deletions of MSH2 and MLH1 in colorectal cancer families detected by a novel mutation detection approach

被引:124
作者
Gille, JJP
Hogervorst, FBL
Pals, G
Wijnen, JT
van Schooten, RJ
Dommering, CJ
Meijer, GA
Craanen, ME
Nederlof, PM
de Jong, D
McElgunn, CJ
Schouten, JP
Menko, FH
机构
[1] VU Univ, Med Ctr, Dept Clin Genet & Human Genet, Canc Family Clin, NL-1007 MB Amsterdam, Netherlands
[2] VU Univ, Med Ctr, Dept Pathol, NL-1007 MB Amsterdam, Netherlands
[3] VU Univ, Med Ctr, Dept Gastroenterol, NL-1007 MB Amsterdam, Netherlands
[4] Netherlands Canc Inst, Canc Family Clin, NL-1066 CX Amsterdam, Netherlands
[5] Netherlands Canc Inst, Dept Pathol, NL-1066 CX Amsterdam, Netherlands
[6] Leiden Univ, Med Ctr, Dept Human Genet, NL-2300 RC Leiden, Netherlands
[7] MRC Holland, NL-1057 SN Amsterdam, Netherlands
关键词
mismatch-repair; HNPCC; genomic deletions; Muir-Torre syndrome;
D O I
10.1038/sj.bjc.6600565
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Hereditary non-polyposis colorectal cancer is an autosomal dominant condition due to germline mutations in DNA-mismatch-repair genes, in particular MLH1, MSH2 and MSH6. Here we describe the application of a novel technique for the detection of genomic deletions in MLH1 and MSH2. This method, called multiplex ligation-dependent probe amplification, is a quantitative multiplex PCR approach to determine the relative copy number of each MLH1 and MSH2 exon. Mutation screening of genes was performed in 126 colorectal cancer families selected on the basis of clinical criteria and in addition, for a subset of families, the presence of microsatellite instability (MSI-high) in tumours. Thirty-eight germline mutations were detected in 37 (29.4%) of these kindreds, 31 of which have a predicted pathogenic effect. Among families with MSI-high tumours 65.7% harboured germline gene defects, Genomic deletions accounted for 54.8% of the pathogenic mutations. A complete deletion of the MLH1 gene was detected in two families. The multiplex ligation-dependent probe amplification approach is a rapid method for the detection of genomic deletions in MLH1 and MSH2. In addition, it reveals alterations that might escape detection using conventional diagnostic techniques. Multiplex ligation-dependent probe amplification might be considered as an early step in the molecular diagnosis of hereditary non-polyposis colorectal cancer. (C) 2002 Cancer Research UK.
引用
收藏
页码:892 / 897
页数:6
相关论文
共 28 条
  • [1] Measurement of locus copy number by hybridisation with amplifiable probes
    Armour, JAL
    Sismani, C
    Patsalis, PC
    Cross, G
    [J]. NUCLEIC ACIDS RESEARCH, 2000, 28 (02) : 605 - 609
  • [2] Family history characteristics, tumor microsatellite instability and germline MSH2 and MLH1 mutations in hereditary colorectal cancer
    Bapat, BV
    Madlensky, L
    Temple, LKF
    Hiruki, T
    Redston, M
    Baron, DL
    Xia, L
    Marcus, VA
    Soravia, C
    Mitri, A
    Shen, W
    Gryfe, R
    Berk, T
    Chodirker, BN
    Cohen, Z
    Gallinger, S
    [J]. HUMAN GENETICS, 1999, 104 (02) : 167 - 176
  • [3] Molecular and clinical characteristics of MSH6 variants:: An analysis of 25 index carriers of a germline variant
    Berends, MJW
    Wu, Y
    Sijmons, RH
    Mensink, RGJ
    van der Sluis, T
    Hordijk-Hos, JM
    de Vries, EGE
    Hollema, H
    Karrenbeld, A
    Buys, CHCM
    van der Zee, AGJ
    Hofstra, RMW
    Kleibeuker, JH
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 2002, 70 (01) : 26 - 37
  • [4] Boland CR, 1998, CANCER RES, V58, P5248
  • [5] Charbonnier F, 2000, CANCER RES, V60, P2760
  • [6] Charbonnier F, 2002, CANCER RES, V62, P848
  • [7] Systematic analysis of hMSH2 and hMLH1 in young colon cancer patients and controls
    Farrington, SM
    Lin-Goerke, J
    Ling, J
    Wang, YT
    Burczak, JD
    Robbins, DJ
    Dunlop, MG
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 1998, 63 (03) : 749 - 759
  • [8] Microsatellite instability - a useful diagnostic tool to select patients at high risk for hereditary non-polyposis colorectal cancer: a study in different groups of patients with colorectal cancer
    Lamberti, C
    Kruse, R
    Ruelfs, C
    Caspari, R
    Wang, Y
    Jungck, M
    Mathiak, M
    Malayeri, HRH
    Friedl, W
    Sauerbruch, T
    Propping, P
    [J]. GUT, 1999, 44 (06) : 839 - 843
  • [9] Liu T, 2001, CANCER RES, V61, P7798
  • [10] Mauillon JL, 1996, CANCER RES, V56, P5728